/ Published in 2022, Publication

Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls – the DoRIS Randomised Trial.

Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls – the DoRIS Randomised Trial.
Jones, D. W., Changalucha, J., Whitworth, H., Pinto, L. A., Mutani, P., Indangasi, J., Kemp, T. J., Hashim, R., Kamala, B., Wiggins, R., Songoro, T., Connor, N., Mbwanji, G., Pavon, M., Lowe, B., Mmbando, D., Kapiga, S., Mayaud, P., Dillner, J., … Baisley, K.
SSRN Electronic Journal.
DOI: https://doi.org/10.2139/ssrn.4055429.

What you can read next

Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.
The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring.
The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa.